San Jose, CA, United States of America

Kilian Horgan

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Medarex Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kilian Horgan. Retrieved from https://idiyas.com/inventor/kilian-horgan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kilian Horgan: Innovator in Drug-Ligand Conjugates

Introduction

Kilian Horgan is a notable inventor based in San Jose, CA. He has made significant contributions to the field of drug development, particularly in the area of chemical linkers and conjugates. His innovative work has the potential to impact therapeutic strategies in medicine.

Latest Patents

Kilian Horgan holds 1 patent for his invention titled "Chemical linkers and conjugates thereof." This patent provides drug-ligand conjugates that are potent cytotoxins, wherein the drug is linked to the ligand through either a peptidyl, hydrazine, or disulfide linker. The disclosure also includes compositions containing these drug-ligand conjugates and methods of treatment utilizing them.

Career Highlights

Throughout his career, Kilian has worked with prominent companies in the pharmaceutical industry, including Medarex Inc. and E.R. Squibb & Sons, L.L.C. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Kilian has collaborated with several professionals in his field, including Sharon Elaine Boyd and Liang Chen. These partnerships have likely enhanced his research and development efforts.

Conclusion

Kilian Horgan is a distinguished inventor whose work in drug-ligand conjugates showcases his innovative spirit and dedication to advancing medical treatments. His contributions are valuable to the ongoing evolution of pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…